FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Tocilizumab Injection
Status: Currently in Shortage
»Date first posted: 08/17/2021
»Therapeutic Categories: Rheumatology

Expand all

Genentech, Inc (Reverified 11/29/2021)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
200mg/10mL, (NDC 50242-0136-01) Available Demand increase for the drug
400mg/20mL, (NDC 50242-0137-01) Available Demand increase for the drug
80mg/4mL, (NDC 50242-0135-01) Available Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English